BRIACELL THERAPEUTICS CORP. (BCTX) Operating income 2021–2026
BRIACELL THERAPEUTICS CORP. (BCTX) annual operating income history from SEC filings — each fiscal year as reported.
-$36.1MFY2026 · since FY2021: -$7.0M → -$36.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$36.1M | -32.5% |
| FY2025 | -$27.2M | +18.4% |
| FY2024 | -$33.3M | -43.2% |
| FY2023 | -$23.3M | -52.2% |
| FY2022 | -$15.3M | -119.2% |
| FY2021 | -$7.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BCTX financial trends
BCTX RevenueBCTX Net incomeBCTX Net marginBCTX Gross profitBCTX Gross marginBCTX Operating marginBCTX Operating cash flowBCTX Free cash flowBCTX Capital expendituresBCTX Return on equityBCTX Stock buybacksBCTX Dividends paidBCTX Total assetsBCTX Total liabilitiesBCTX Shareholders’ equityBCTX overview →